The pancreatic β cell and type 1 diabetes: Innocent bystander or active participant?

Trends in Endocrinology and Metabolism

Volumn 24, Issue 7, 2013, Pages 324-331

  Soleimanpour, Scott A ^a   Stoffers, Doris A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

GWAS; Insulin; Islet; T1DM

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; CELL FUNCTION; DISEASE COURSE; DNA SEQUENCE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; GENETIC VARIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INSULIN-SECRETING CELLS; LYMPHOCYTE ACTIVATION; LYSOSOMES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84879459923     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.03.005     Document Type: Review

References (100)

1. Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in The United States, 2011 2011, United States Department of Health and Human Services.
2. Hyttinen V., et al. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 2003, 52:1052-1055.
3. Bluestone J.A. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
4. Bell G.I., et al. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984, 33:176-183.
5. Cooper J.D., et al. Confirmation of novel type 1 diabetes risk loci in families. Diabetologia 2012, 55:996-1000.
6. Moran I., et al. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 2012, 16:435-448.
7. Eizirik D.L., et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012, 8:e1002552.
8. Kutlu B., et al. Detailed transcriptome atlas of the pancreatic beta cell. BMC Med. Genomics 2009, 2:3.
9. Eizirik D.L., et al. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 2009, 5:219-226.
10. Barrett J.C., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 41:703-707.
11. Wallace C., et al. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat. Genet. 2010, 42:68-71.
12. Reddy M.V., et al. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun. 2011, 12:208-212.
13. Senee V., et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat. Genet. 2006, 38:682-687.
14. Dupuis J., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42:105-116.
15. Kang H.S., et al. Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression. Mol. Cell. Biol. 2009, 29:6366-6379.
16. Yang Y., et al. Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adults. EMBO Mol. Med. 2013, 5:92-104.
17. Schmidt J.V., et al. The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev. 2000, 14:1997-2002.
18. Harjutsalo V., et al. Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 2006, 55:1517-1524.
19. Yevtodiyenko A., Schmidt J.V. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev. Dyn. 2006, 235:1115-1123.
20. Carlsson C., et al. Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/delta-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology 1997, 138:3940-3948.
21. Friedrichsen B.N., et al. Expression, biosynthesis and release of preadipocyte factor-1/delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications. J. Endocrinol. 2003, 176:257-266.
22. Appelbe O.K., et al. Conditional deletions refine the embryonic requirement for Dlk1. Mech. Dev. 2013, 130:143-159.
23. Whitcomb D.C., Lowe M.E. Human pancreatic digestive enzymes. Dig. Dis. Sci. 2007, 52:1-17.
24. Hoffman B.G., et al. Identification of transcripts with enriched expression in the developing and adult pancreas. Genome Biol. 2008, 9:R99.
25. Frier B.M., et al. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 1976, 17:685-691.
26. Creutzfeldt W., et al. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 2005, 72:71-75.
27. Kim Y.J., et al. IDDM patients' sera recognize a novel 30-kD pancreatic autoantigen related to chymotrypsinogen. Immunol. Invest. 1993, 22:219-227.
28. Malaisse-Lagae F., et al. Exocrine pancreas: evidence for topographic partition of secretory function. Science 1975, 190:795-797.
29. Moustakas A.K., Papadopoulos G.K. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells. Am. J. Med. Genet. 2002, 115:37-47.
30. Reusch U., et al. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 1999, 18:1081-1091.
31. Turner M.D., Arvan P. Protein traffic from the secretory pathway to the endosomal system in pancreatic beta-cells. J. Biol. Chem. 2000, 275:14025-14030.
32. Platta H.W., Stenmark H. Endocytosis and signaling. Curr. Opin. Cell Biol. 2011, 23:393-403.
33. Huotari J., Helenius A. Endosome maturation. EMBO J. 2011, 30:3481-3500.
34. Awata T., et al. Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J. Clin. Endocrinol. Metab. 2009, 94:231-235.
35. Hakonarson H., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591-594.
36. Kim S., et al. The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation. J. Cell Biol. 2010, 188:717-734.
37. Miettinen P., et al. EGF receptor in pancreatic beta-cell mass regulation. Biochem. Soc. Trans. 2008, 36:280-285.
38. Goulley J., et al. BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion. Cell Metab. 2007, 5:207-219.
39. Faculty Synopses Monogenic disorders of insulin secretion: congenital hyperinsulinism and neonatal diabetes, March 15-16, 2012. Pediatr. Diabetes 2012, 13:337-361.
40. Kim S., et al. Drosophila Golgi membrane protein Ema promotes autophagosomal growth and function. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E1072-E1081.
41. Chen Z.F., et al. The double-edged effect of autophagy in pancreatic beta cells and diabetes. Autophagy 2011, 7:12-16.
42. Todd J.A., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007, 39:857-864.
43. Christoforidis S., et al. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat. Cell Biol. 1999, 1:249-252.
44. Velazquez L., et al. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 1992, 70:313-322.
45. Smyth D.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 2006, 38:617-619.
46. Keene K.L., et al. Evidence for two independent associations with type 1 diabetes at the 12q13 locus. Genes Immun. 2012, 13:66-70.
47. Erickson S.L., et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 1997, 124:4999-5011.
48. Kritzik M.R., et al. Expression of ErbB receptors during pancreatic islet development and regrowth. J. Endocrinol. 2000, 165:67-77.
49. Coppieters K.T., et al. Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin. Exp. Immunol. 2012, 168:5-11.
50. Takeuchi O., Akira S. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 2008, 20:17-22.
51. Dogusan Z., et al. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 2008, 57:1236-1245.
52. Garcia M., et al. Regulation and function of the cytosolic viral RNA sensor RIG-I in pancreatic beta cells. Biochim. Biophys. Acta 2009, 1793:1768-1775.
53. Colli M.L., et al. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Hum. Mol. Genet. 2010, 19:135-146.
54. Nejentsev S., et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
55. Downes K., et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS ONE 2010, 5:e12646.
56. Moore F., et al. PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis. Diabetes 2009, 58:1283-1291.
57. Santin I., et al. PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic beta-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 2011, 60:3279-3288.
58. Melloul D. Role of NF-kappaB in beta-cell death. Biochem. Soc. Trans. 2008, 36:334-339.
59. Mercurio F., et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997, 278:860-866.
60. Palombella V.J., et al. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994, 78:773-785.
61. Eldor R., et al. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5072-5077.
62. Kim S., et al. NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1913-1918.
63. Norlin S., et al. Nuclear factor-κB activity in β-cells is required for glucose-stimulated insulin secretion. Diabetes 2005, 54:125-132.
64. Sarkar S.A., et al. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 2009, 52:1092-1101.
65. Liuwantara D., et al. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes 2006, 55:2491-2501.
66. Grey S.T., et al. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J. Exp. Med. 1999, 190:1135-1146.
67. Grey S.T., et al. Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J. Immunol. 2003, 170:6250-6256.
68. Bergholdt R., et al. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 2012, 61:954-962.
69. Berchtold L.A., et al. Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E681-E688.
70. Karlsen A.E., et al. Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3. Biochem. Biophys. Res. Commun. 2006, 344:406-415.
71. Bergholdt R., et al. Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets. Genes Immun. 2007, 8:232-238.
72. Rashid M.A., et al. Carbonyl reductase 1 protects pancreatic beta-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity. Free Radic. Biol. Med. 2010, 49:1522-1533.
73. Suizu F., et al. The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. Dev. Cell 2009, 17:800-810.
74. Roggli E., et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 2010, 59:978-986.
75. Ruan Q., et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12030-12035.
76. Roggli E., et al. Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice. Diabetes 2012, 61:1742-1751.
77. Brehm M.A., et al. Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harb. Perspect. Med. 2012, 2:a007757.
78. Nostro M.C.G., Keller G. Generation of beta cells from human pluripotent stem cells: potential for regenerative medicine. Semin. Cell Dev. Biol. 2012, 23:701-710.
79. Makino S., et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980, 29:1-13.
80. Rossini A.A., et al. Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes 1979, 28:1031-1032.
81. van Belle T.L., et al. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011, 91:79-118.
82. Shoda L.K., et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005, 23:115-126.
83. Ize-Ludlow D., et al. Progressive erosion of beta-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Diabetes 2011, 60:2086-2091.
84. Marhfour I., et al. Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 2012, 55:2417-2420.
85. Tersey S.A., et al. Islet beta-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 2012, 61:818-827.
86. O'Sullivan-Murphy B., Urano F. ER stress as a trigger for beta-cell dysfunction and autoimmunity in type 1 diabetes. Diabetes 2012, 61:780-781.
87. Nerup J., et al. HL-A antigens and diabetes mellitus. Lancet 1974, 2:864-866.
88. Jahromi M.M., Eisenbarth G.S. Cellular and molecular pathogenesis of type 1A diabetes. Cell. Mol. Life Sci. 2007, 64:865-872.
89. Noble J.A., et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010, 59:2972-2979.
90. Marron M.P., et al. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13753-13758.
91. Foulis A.K., et al. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987, 30:333-343.
92. Foulis A.K., et al. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987, 2:1423-1427.
93. Pujol-Borrell R., et al. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin. Exp. Immunol. 1986, 65:128-139.
94. Stewart T.A., et al. Induction of type I diabetes by interferon-alpha in transgenic mice. Science 1993, 260:1942-1946.
95. Coppieters K.T., et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 2012, 209:51-60.
96. Pavlovic D., et al. Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J. Clin. Endocrinol. Metab. 1997, 82:2329-2336.
97. In't Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011, 3:131-138.
98. In't Veld P., et al. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 2007, 56:2400-2404.
99. Keenan H.A., et al. Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010, 59:2846-2853.
100. Sherry N.A., et al. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 2006, 55:3238-3245.